BBP

BioShares Biotechnology Products ETF

Down$41.46
$-0.42
(-1%)
As of 2:50:38 PM EDT | 1/27/20  |  Market Open

BBP Trading Data

Open

$41.33

Low Price

$41.15

High Price

$41.46

Previous Last Price

$41.88

Bid Size

$41.54 X 300

Ask Size

$41.64 X 300

BBP Portfolio Data

AUM

$25,164,000

Shares

600

PE Ratio

0

Price / Book Ratio

4.65

Expense Ratio

0.79

Net Asset Value

$41.94

Volume

Volume

1,705

Avg. Volume (YDT)

2,953

Dollar Volume

$146,515

Weekly Avg. Volume

2,361

Monthly Avg. Volume

3,085

Quarterly Avg. Volume

3,005

BBP Fund Description

The BioShares Biotechnology Products Fund seeks investment results that correspond to the performance of the BioShares Biotechnology Products Index. Products stage companies are typically more established companies with much clinical trial failure risk behind them.

BBP Chart

BBP Summary

Fund Family

BioShares

Tracks This Index

BioShares Biotechnology Products ETF

Inception Date

2014-12-17

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

BBP Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

BBP Holdings

Top 10 Holdings

Momenta Pharmaceuticals Inc (MNTA)
3.88%
Ultragenyx Pharmaceutical Inc (RARE)
3.06%
Theravance Biopharma Inc (TBPH)
2.71%
Retrophin Inc (RTRX)
2.65%
Agios Pharmaceuticals Inc (AGIO)
2.61%
PTC Therapeutics Inc (PTCT)
2.53%
Exelixis Inc (EXEL)
2.51%
BioMarin Pharmaceutical Inc (BMRN)
2.44%
Vertex Pharmaceuticals Inc (VRTX)
2.43%
Aimmune Therapeutics Inc (AIMT)
2.41%

Total BBP Holdings

Total Holdings: 47

Momenta Pharmaceuticals Inc (MNTA)
3.88%
Ultragenyx Pharmaceutical Inc (RARE)
3.06%
Theravance Biopharma Inc (TBPH)
2.71%
Retrophin Inc (RTRX)
2.65%
Agios Pharmaceuticals Inc (AGIO)
2.61%
PTC Therapeutics Inc (PTCT)
2.53%
Exelixis Inc (EXEL)
2.51%
BioMarin Pharmaceutical Inc (BMRN)
2.44%
Vertex Pharmaceuticals Inc (VRTX)
2.43%
Aimmune Therapeutics Inc (AIMT)
2.41%
Acceleron Pharma Inc (XLRN)
2.39%
Global Blood Therapeutics Inc (GBT)
2.37%
Halozyme Therapeutics Inc (HALO)
2.37%
Karyopharm Therapeutics Inc (KPTI)
2.37%
Nektar Therapeutics (NKTR)
2.34%
Omeros Corp (OMER)
2.34%
United Therapeutics Corp (UTHR)
2.32%
Seattle Genetics Inc (SGEN)
2.31%
Ironwood Pharmaceuticals Inc (IRWD)
2.29%
Alnylam Pharmaceuticals Inc (ALNY)
2.29%
Amgen Inc (AMGN)
2.27%
Akcea Therapeutics Inc (AKCA)
2.27%
Alexion Pharmaceuticals Inc (ALXN)
2.25%
Amicus Therapeutics Inc (FOLD)
2.25%
Gilead Sciences Inc (GILD)
2.22%
Sage Therapeutics Inc (SAGE)
2.21%
BeiGene Ltd (BGNE)
2.19%
Ionis Pharmaceuticals Inc (IONS)
2.19%
Biogen Inc (BIIB)
2.18%
Regeneron Pharmaceuticals Inc (REGN)
2.17%
Neurocrine Biosciences Inc (NBIX)
2.11%
ACADIA Pharmaceuticals Inc (ACAD)
2.1%
Vanda Pharmaceuticals Inc (VNDA)
2.05%
Intercept Pharmaceuticals Inc (ICPT)
2%
Insmed Inc (INSM)
1.99%
Sarepta Therapeutics Inc (SRPT)
1.97%
Incyte Corp (INCY)
1.95%
Ligand Pharmaceuticals Inc (LGND)
1.94%
Radius Health Inc (RDUS)
1.93%
Enanta Pharmaceuticals Inc (ENTA)
1.92%
Clovis Oncology Inc (CLVS)
1.64%
Lexicon Pharmaceuticals Inc (LXRX)
1.62%
Stemline Therapeutics Inc (STML)
1.58%
BNY MELLON CASH RESERVE USD
1.33%
Portola Pharmaceuticals Inc (PTLA)
1.19%
Virtus LifeSci Biotech Products ETF (BBP)
0%
Cash/Cash equivalents
0%

BBP Technicals

Alpha

-5.5

Beta

1.57

Leverage

Long

Standard Deviation

2.83

BBP Dividends

Dividend Date

2017-12-20

Latest Dividend

0.072

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

BBP Performance

YTD Return

-4.76%

1 Year Return

2.09%

3 Year Return

22.03%

5 Year Return

49.57%

10 Year Return

60.34%

BBP Related Articles

© 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.